温郁金化学成分及莪术醇大鼠体内代谢研究
|
摘要
温郁金为姜科姜黄属(Curcuma)多年生草本植物温郁金Curcuma wenyijin的干燥根茎,分布于我国浙江省。在中国及日本的传统用药中,温郁金常用于治疗血液循环综合症,即由血液循环障碍引起的炎症,如关节痛,痛经等。其挥发油作为抗病毒,抗肿瘤药物收载于2005年《中华人民共和国药典》。前期的研究结果表明,温郁金中主要含有倍半萜类和二苯庚烷类化学成分,其中部分成分具有显著的舒张血管作用和保肝作用。为进一步明确其生物活性成分,了解其发挥药效的物质基础,本论文对温郁金的干燥根茎进行了较系统的化学研究,利用现代色谱分离手段,从温郁金中分离得到43个化合物,通过各种谱学数据(UV、NMR、MS)分析鉴定了40个化合物,包括三十三个倍半萜类化合物:其中十六个愈创木烷型化合物zedoalactone D(3)、zedoalactone E(4)、zedoalactone F(5)、zedoalactone H(6)、(1S,4S,5S,10R)-zedoarondiol(7)、procurcumenol(14)、zedoarondiol(15)、isozedoarondiol(16)、zedoalactone A(17)、zedoalactone B(18)、zedoalactone C(19)、aerugidiol(20)、zedoarolide B(21)、curcumenol(22)、curcumol(23)、alismoxide(24);八个吉玛烷型化合物:curdionolide A(9)、curdionolide B(10)、curdionolideC(11)、curdione(25)、(4S,5S)-(+)-germacrone-4,5-epoxide(26)、(1S,10S),(4S,5S)-(+)-germacrone-1(10),4-diepoxide(27)、aeruginolactone(28)、(1E,4Z)-8-hydroxy-6-oxogermacra-1(10),4,7(11)-trieno-12,8-lactone(29);四个桉烷型化合物:curcodione(1)、curcolide(2)、1β,4α-dihydroxy-5α,8β(H)-eudesm-7(11)Z-en-12,8-olide(32)、curcolonol(33);二个卡拉布烷型化合物:curcumenone(30)、4S-dihydrocurcumeno-ne(31);一个榄烷型化合物:hydroxyisogermafurenolide(34);一个苍耳烷型化合物:curcumadionol(12);一个裂环吉玛烷型化合物:6R-dehydroxylsipanolinolide(8);二个二苯庚烷类化合物:dicurcuminol(13)、1,5-epoxy-3α-hydroxyl-1-(3,4-dihydroxy-5-metho-xyphenyl)-7-(4-hydro-xy-3-methoxyphenyl)heptane(35);二个酚酸类衍生物femlic acid(36)、p-hydroxy cinnamicacid(37);一个黄酮类化合物5,7,4'-trihydroxy-flavanone(38);二个甾醇及其苷类daucosterol(39)、β-sitosterol(40)。新化合物13个(化合物1-13),其中化合物13是具有六元吡喃环结构的二苯庚烷二倍体,具有该骨架的二苯庚烷型化合物至今未见有文献报道,化合物11是首次发现的吉玛烷内酰胺类化合物;首次从本属植物中分离得到的化合物4个(化合物29、32、35、38)。首次从该种植物中分离得到的化合物6个(化合物14、24、28、33、36、37)。上述研究结果丰富了温郁金化学成分的结构类型,同时为进一步的生物活性研究奠定了物质基础。
一氧化氮(NO)是在生物体内由L-精氨酸(L-arginine,L-Arg)在一氧化氮合酶(NOS)的作用下生成的一种无机小分子自由基,是一种生物体内重要的信使分子和神经递质,参与调节机体的许多生理或病理过程,如血管舒张,非特异性宿主防御反应,局部缺血再灌损伤,慢性或急性炎症反应等。研究证实在一些类型的细胞如巨噬细胞,上皮细胞,和平滑肌细胞中通过应答一些前炎症因子如白介素-1β(IL-1β),肿瘤坏死因子(TNF-α)和脂多糖(LPS)等的刺激可以刺激其中诱导型一氧化氮合酶(iNOS)表达而导致过量产生NO。论文采用Griess法考察了其中38个化合物抑制脂多糖诱导的大鼠RAW264.7巨噬细胞NO释放活性,结果表明有6个倍半萜类化合物(化合物22,26,28,31,34,35)表现出很强的活性。另外,化合物25表现出与阳性对照药接近的抑制活性,化合物1,5,29,32较弱的抑制活性。其他化合物的IC_(50)值均大于100,没有表现出抑制活性。这些化合物对NO的抑制作用初步阐明了倍半萜类,二苯庚烷类化合物是治疗关节痛,痛经等血液循环阻碍引起的炎症的主要活性物质。
2005版药典规定莪术醇为临床抗病毒、抗肿瘤用药莪术油质量控制的指标成分。近年研究发现莪术醇具有与莪术油一致的药理活性,因此,莪术醇是莪术油的主要药效成分之一。有关莪术醇的体内代谢研究截至目前仅有一篇文献报道,但代谢产物并未明确。本室已毕业的张卉博士曾经对莪术醇大鼠体内的代谢进行了阶段性研究,分离鉴定了10种代谢产物。为了全面了解莪术醇体内代谢信息,本论文继续对莪术醇的体内代谢进行了研究。
利用现代色谱分离手段,从大鼠灌胃莪术醇的尿液中共分离得到了17个莪术醇的代谢产物,通过波谱学等手段确定其中14个代谢产物的结构。分别为:10α,14,15-trihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-1),10α-hydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-2),10α-hydroxy-(1αH,7βH)-guai-4-en-3,8-dioxo-12-oic acid(M-3),(1αH,7βH)-guai-4,10(14)-dien-3,8-dioxo-12-oic acid(M-4),5p,10β-dihydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxide(M-5),5α,10β-dihydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxide(M-6),8β-hydroxy-(1αH,7βH,11βH)-guai-8(12)-epoxy-4,10(14)-dien-3-one(M-7),10β,14-dihy-droxy curcumol(M-8),5β,10β,14-trihydroxy-(1αH,7βH)-guai-8-one(M-9),10β-hydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-10),10β-hydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-11),10α-hydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-12),10β,14-dihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-13),10α,14-dihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-14)。所有的代谢产物都是一相代谢产物,其中9个代谢产物为新化合物(M-1～M-9),并且M-2、M-10、M-11、M-12;M-13、M-14;M-5、M-6是三对立体异构体。根据分离得到的代谢产物,我们发现莪术醇在大鼠体内主要发生羟基化、环氧化、醇氧化、脱水、水合反应、缩酮化、环氧环开环反应。
本论文通过对莪术醇在哺乳动物体内代谢产物进行研究,明确了其在体内的代谢途径和转化过程,为其进一步研究提供了重要的体内代谢信息。
Curcuma wenyujin,a perennial herbaceous plant of Zingiberaceae,is distributed in the south of China,especially in Zhejiang Province.In traditional Chinese and Japanese medicine, the rhizomes of Curcuma wenyujin are generally used to treat the Oketsu syndromes(various syndromes caused by the obstruction of blood circulation such as arthralgia and dysmenorrhea).The essential oil of Curcuma wenyujin is currently embodied in the Pharmacopoeia of the P.R.China(2005),as an anti-cancer and anti-virus remedy.Previous chemical investigations on the Curcuma wenyujin have led to the isolation of sesquiterpenoids and diarylheptanoids,some of these compounds possess significant vasorelaxant and hepatoprotective activities.In order to clarify the bioactive constituents of Curcuma wenyujin, the systematic investigation on the chemical constituents was carried out.As a result,43 compounds were isolated from the rhizomes of Curcuma wenyujin.On the basis of chemical evidences and spectral analysis,the structures of 40 compounds were elucidated as follows: sixteen guaiane-type sesquiterpenes:zedoalactone D(3),zedoalactone E(4),zedoalactone F(5),zedoalactone H(6),(1S,4S,5S,10R)-zedoarondiol(7),procurcumenol(14),zedoaron -diol(15),isozedoarondiol(16),zedoalactone A(17),zedoalactone B(18),zedoalactone C (19),aerugidiol(20),zedoarolide B(21),curcumenol(22),curcumol(23),and alismoxide (24);eight germacrane-type sesquiterpenes:curdionolide A(9),curdionolide B(10), curdionolide C(11),curdione(25),(4S,5S)-(+)-germacrone-4,5-epoxide(26), (1S,10S),(4S,5S)-(+)-germacrone- 1(10)-4-diepoxide(27),aeruginolactone(28),and(1E,4Z) -8-hydroxy-6-oxogermacra- 1(10),4,7(11)-trieno- 12,8-lactone(29);four eudesmane-type sesquiterpenes:curcodione(1),curcolide(2),1β,4α-dihydroxy-5α,8β(H)-eudesm-7(11) Z-en -12,8-olide(32),and curcolonol(33);two carabrane-type sesquiterpenes:curcumenone(30) and 4S-dihydrocurcumenone(31);one elemane-type sesquiterpene:hydroxyiso germafurenolide (34);one xanthane-type sesquiterpene:curcumadionol(12);one seco-germacrane -type sesquiterpene:6R-dehydroxylsipanolinolide(8);two diarylheptanoids:dicurcuminol (13),and 1,5-epoxy-3α-hydroxyl-1-(3,4-dihydroxy-5-methoxyphenyl)-7-(4-hydroxy-3-meth -oxy-phenyl)heptane(35);two phenolic acid derivatives:ferulic acid(36),and p-hydroxy cinnamic acid(37);one flavonoid:5,7,4'-trihydroxy-flavanone(38);one sterol and its glycoside:daucosterol(39),andβ-sitosterol(40).Among them,Thirteen compounds(1-13) were new compounds,13 was a novel compound with new skeleton;11,a novel nitrogen-containing germacrane-type sesquiterpene,has been isolated from natural sources for the first time.Four compounds(29,32,35,38) were isolated for the first time from the plants of this genus.Six compounds(14.24,28,33,36,37) were isolated for the first time from the plants.
The investigation enriched the constituent-types of C.wenyujin and could provide material basic for further activity screening.
The inorganic free radical NO has been implicated in physiological and pathological processes,such as vasodilation,nonspecific host defense,ischemia reperfusion injury,and chronic or acute inflammation.NO is produced by the oxidation of L-arginine by NO synthase(NOS).In the NOS family,inducible NOS in particular is involved in a pathological aspect with overproduction of NO,and can be expressed in response to pro-inflammatory agents such as interleukin-1β,tumor necrosis factor-α,and LPS in various cells including macrophages,endothelial cells,and smooth muscle cells.In this thesis,we investigated the inhibitory effects of the 38 compounds on NO production in LPS-activated macrophages by Griess method.
Among the tested compounds,6 sesquiterpenes(22,26,28,31,34 and 35) displayed potent inhibitory effects,compound 25 exhibited moderate activities,which were close to that of hydrocortisone.Compounds 1,5,29 and 32 showed very weak activities.And other compounds showed no activity.
Curcumol is one of the representative index components in the quality standard of the essential oil which is currently used as an anti-cancer and anti-virus remedy,and embodied in the Pharmacopoeia of the P.R.China(2005).Recent studies suggested that the pharmacological activities of curcumol were consistent with those of the essential oil. Therefore,curcumol is one of the major bioactive components of the essential oil.Although a variety of biological activities have been reported for curcumol,there is so far only one research report on its metabolism.In order to characterize its biotransformation in mammalian animals,curcumol was orally administered in rats,and the urinary metabolites were investigated.Dr.Hui Zhang in our group previously isolated and identified 10 metabolites.In our continuous study,17 metabolites were isolated from the urine,and the structures of the 14 ones were elucidated as:10α,14,15-trihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-1), 10α-hydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-2),10β-hydroxy-(1αH,7βH) -guai-4-en-3,8-dioxo- 12-oic acid(M-3),(1αH,7βH)-guai-4,10(14)-dien-3,8-dioxo -12-oic acid(M-4),5β,10β-dihydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxide(M-5), 5α,10β-dihydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxide(M-6),8β-hydroxy-(1αH,7βH,11βH)-guai-8(12)-epoxy-4,10(14)-dien-3-one(M-7),10β,14-dihydroxy curcumol(M-8), 5β,10β,14-trihydroxy-(1αH,7βH)-guai-8-one(M-9),10β-hydroxy-(1αH,7βH,11αH)-guai-8 (12),8(14)-diepoxy-4-en-3-one(M-10),10β-hydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxy -4-en-3-one(M-11),10α-hydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxy-4-en-3 -one(M-12),10β,14-dihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-13),10α,14-dihydroxy -(1αH,7βH)-guai-4-en-3,8-dione(M-14),respectively.All the metabolites are phase 1 metabolites,and nine metabolites are new compounds(M-1-M-9),among which M-2,M-10, M-11,and M-12;M-13 and M-14;M-5 and M-6 are three pairs of epimeric metabolites. Based on the identified metabolites,we could find that hydroxylation,epoxidation,alcohol oxidation,dehydration,ketalization and epoxy-ring opening reaction are the main phase 1 metabolic passways of curcumol in rats.
The study on the metabolism of curcumol in rats would clarify its metabolic pathway and metabolic rules,and provide the important information for its development and further investigation.
一氧化氮(NO)是在生物体内由L-精氨酸(L-arginine,L-Arg)在一氧化氮合酶(NOS)的作用下生成的一种无机小分子自由基,是一种生物体内重要的信使分子和神经递质,参与调节机体的许多生理或病理过程,如血管舒张,非特异性宿主防御反应,局部缺血再灌损伤,慢性或急性炎症反应等。研究证实在一些类型的细胞如巨噬细胞,上皮细胞,和平滑肌细胞中通过应答一些前炎症因子如白介素-1β(IL-1β),肿瘤坏死因子(TNF-α)和脂多糖(LPS)等的刺激可以刺激其中诱导型一氧化氮合酶(iNOS)表达而导致过量产生NO。论文采用Griess法考察了其中38个化合物抑制脂多糖诱导的大鼠RAW264.7巨噬细胞NO释放活性,结果表明有6个倍半萜类化合物(化合物22,26,28,31,34,35)表现出很强的活性。另外,化合物25表现出与阳性对照药接近的抑制活性,化合物1,5,29,32较弱的抑制活性。其他化合物的IC_(50)值均大于100,没有表现出抑制活性。这些化合物对NO的抑制作用初步阐明了倍半萜类,二苯庚烷类化合物是治疗关节痛,痛经等血液循环阻碍引起的炎症的主要活性物质。
2005版药典规定莪术醇为临床抗病毒、抗肿瘤用药莪术油质量控制的指标成分。近年研究发现莪术醇具有与莪术油一致的药理活性,因此,莪术醇是莪术油的主要药效成分之一。有关莪术醇的体内代谢研究截至目前仅有一篇文献报道,但代谢产物并未明确。本室已毕业的张卉博士曾经对莪术醇大鼠体内的代谢进行了阶段性研究,分离鉴定了10种代谢产物。为了全面了解莪术醇体内代谢信息,本论文继续对莪术醇的体内代谢进行了研究。
利用现代色谱分离手段,从大鼠灌胃莪术醇的尿液中共分离得到了17个莪术醇的代谢产物,通过波谱学等手段确定其中14个代谢产物的结构。分别为:10α,14,15-trihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-1),10α-hydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-2),10α-hydroxy-(1αH,7βH)-guai-4-en-3,8-dioxo-12-oic acid(M-3),(1αH,7βH)-guai-4,10(14)-dien-3,8-dioxo-12-oic acid(M-4),5p,10β-dihydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxide(M-5),5α,10β-dihydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxide(M-6),8β-hydroxy-(1αH,7βH,11βH)-guai-8(12)-epoxy-4,10(14)-dien-3-one(M-7),10β,14-dihy-droxy curcumol(M-8),5β,10β,14-trihydroxy-(1αH,7βH)-guai-8-one(M-9),10β-hydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-10),10β-hydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-11),10α-hydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-12),10β,14-dihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-13),10α,14-dihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-14)。所有的代谢产物都是一相代谢产物,其中9个代谢产物为新化合物(M-1～M-9),并且M-2、M-10、M-11、M-12;M-13、M-14;M-5、M-6是三对立体异构体。根据分离得到的代谢产物,我们发现莪术醇在大鼠体内主要发生羟基化、环氧化、醇氧化、脱水、水合反应、缩酮化、环氧环开环反应。
本论文通过对莪术醇在哺乳动物体内代谢产物进行研究,明确了其在体内的代谢途径和转化过程,为其进一步研究提供了重要的体内代谢信息。
Curcuma wenyujin,a perennial herbaceous plant of Zingiberaceae,is distributed in the south of China,especially in Zhejiang Province.In traditional Chinese and Japanese medicine, the rhizomes of Curcuma wenyujin are generally used to treat the Oketsu syndromes(various syndromes caused by the obstruction of blood circulation such as arthralgia and dysmenorrhea).The essential oil of Curcuma wenyujin is currently embodied in the Pharmacopoeia of the P.R.China(2005),as an anti-cancer and anti-virus remedy.Previous chemical investigations on the Curcuma wenyujin have led to the isolation of sesquiterpenoids and diarylheptanoids,some of these compounds possess significant vasorelaxant and hepatoprotective activities.In order to clarify the bioactive constituents of Curcuma wenyujin, the systematic investigation on the chemical constituents was carried out.As a result,43 compounds were isolated from the rhizomes of Curcuma wenyujin.On the basis of chemical evidences and spectral analysis,the structures of 40 compounds were elucidated as follows: sixteen guaiane-type sesquiterpenes:zedoalactone D(3),zedoalactone E(4),zedoalactone F(5),zedoalactone H(6),(1S,4S,5S,10R)-zedoarondiol(7),procurcumenol(14),zedoaron -diol(15),isozedoarondiol(16),zedoalactone A(17),zedoalactone B(18),zedoalactone C (19),aerugidiol(20),zedoarolide B(21),curcumenol(22),curcumol(23),and alismoxide (24);eight germacrane-type sesquiterpenes:curdionolide A(9),curdionolide B(10), curdionolide C(11),curdione(25),(4S,5S)-(+)-germacrone-4,5-epoxide(26), (1S,10S),(4S,5S)-(+)-germacrone- 1(10)-4-diepoxide(27),aeruginolactone(28),and(1E,4Z) -8-hydroxy-6-oxogermacra- 1(10),4,7(11)-trieno- 12,8-lactone(29);four eudesmane-type sesquiterpenes:curcodione(1),curcolide(2),1β,4α-dihydroxy-5α,8β(H)-eudesm-7(11) Z-en -12,8-olide(32),and curcolonol(33);two carabrane-type sesquiterpenes:curcumenone(30) and 4S-dihydrocurcumenone(31);one elemane-type sesquiterpene:hydroxyiso germafurenolide (34);one xanthane-type sesquiterpene:curcumadionol(12);one seco-germacrane -type sesquiterpene:6R-dehydroxylsipanolinolide(8);two diarylheptanoids:dicurcuminol (13),and 1,5-epoxy-3α-hydroxyl-1-(3,4-dihydroxy-5-methoxyphenyl)-7-(4-hydroxy-3-meth -oxy-phenyl)heptane(35);two phenolic acid derivatives:ferulic acid(36),and p-hydroxy cinnamic acid(37);one flavonoid:5,7,4'-trihydroxy-flavanone(38);one sterol and its glycoside:daucosterol(39),andβ-sitosterol(40).Among them,Thirteen compounds(1-13) were new compounds,13 was a novel compound with new skeleton;11,a novel nitrogen-containing germacrane-type sesquiterpene,has been isolated from natural sources for the first time.Four compounds(29,32,35,38) were isolated for the first time from the plants of this genus.Six compounds(14.24,28,33,36,37) were isolated for the first time from the plants.
The investigation enriched the constituent-types of C.wenyujin and could provide material basic for further activity screening.
The inorganic free radical NO has been implicated in physiological and pathological processes,such as vasodilation,nonspecific host defense,ischemia reperfusion injury,and chronic or acute inflammation.NO is produced by the oxidation of L-arginine by NO synthase(NOS).In the NOS family,inducible NOS in particular is involved in a pathological aspect with overproduction of NO,and can be expressed in response to pro-inflammatory agents such as interleukin-1β,tumor necrosis factor-α,and LPS in various cells including macrophages,endothelial cells,and smooth muscle cells.In this thesis,we investigated the inhibitory effects of the 38 compounds on NO production in LPS-activated macrophages by Griess method.
Among the tested compounds,6 sesquiterpenes(22,26,28,31,34 and 35) displayed potent inhibitory effects,compound 25 exhibited moderate activities,which were close to that of hydrocortisone.Compounds 1,5,29 and 32 showed very weak activities.And other compounds showed no activity.
Curcumol is one of the representative index components in the quality standard of the essential oil which is currently used as an anti-cancer and anti-virus remedy,and embodied in the Pharmacopoeia of the P.R.China(2005).Recent studies suggested that the pharmacological activities of curcumol were consistent with those of the essential oil. Therefore,curcumol is one of the major bioactive components of the essential oil.Although a variety of biological activities have been reported for curcumol,there is so far only one research report on its metabolism.In order to characterize its biotransformation in mammalian animals,curcumol was orally administered in rats,and the urinary metabolites were investigated.Dr.Hui Zhang in our group previously isolated and identified 10 metabolites.In our continuous study,17 metabolites were isolated from the urine,and the structures of the 14 ones were elucidated as:10α,14,15-trihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-1), 10α-hydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxy-4-en-3-one(M-2),10β-hydroxy-(1αH,7βH) -guai-4-en-3,8-dioxo- 12-oic acid(M-3),(1αH,7βH)-guai-4,10(14)-dien-3,8-dioxo -12-oic acid(M-4),5β,10β-dihydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxide(M-5), 5α,10β-dihydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxide(M-6),8β-hydroxy-(1αH,7βH,11βH)-guai-8(12)-epoxy-4,10(14)-dien-3-one(M-7),10β,14-dihydroxy curcumol(M-8), 5β,10β,14-trihydroxy-(1αH,7βH)-guai-8-one(M-9),10β-hydroxy-(1αH,7βH,11αH)-guai-8 (12),8(14)-diepoxy-4-en-3-one(M-10),10β-hydroxy-(1αH,7βH,11βH)-guai-8(12),8(14)-diepoxy -4-en-3-one(M-11),10α-hydroxy-(1αH,7βH,11αH)-guai-8(12),8(14)-diepoxy-4-en-3 -one(M-12),10β,14-dihydroxy-(1αH,7βH)-guai-4-en-3,8-dione(M-13),10α,14-dihydroxy -(1αH,7βH)-guai-4-en-3,8-dione(M-14),respectively.All the metabolites are phase 1 metabolites,and nine metabolites are new compounds(M-1-M-9),among which M-2,M-10, M-11,and M-12;M-13 and M-14;M-5 and M-6 are three pairs of epimeric metabolites. Based on the identified metabolites,we could find that hydroxylation,epoxidation,alcohol oxidation,dehydration,ketalization and epoxy-ring opening reaction are the main phase 1 metabolic passways of curcumol in rats.
The study on the metabolism of curcumol in rats would clarify its metabolic pathway and metabolic rules,and provide the important information for its development and further investigation.
引文
[1]国家药典委员会.中华人民共和国药典(一部)[M].北京:化学工业出版社,2005.194-194.
[2]Hiroshi H.Kangi M.et.al.Structure of curcumol[J].Chem.Pharm.Bull.1965,13,1484-1485.
[3]Hiroshi H,Kangi M,et.al.Srtucture of curcumol[J].Chem.Pharm.Bull.1966,14.1241-1249.
[4]Hiroshi H.Yojiro S,et.al.Structure of curcumenol[J].Chem.Pharm.Bull.1968,16,39-42.
[5]Hidashi M,Toshio M,et.al.Medicinal foodstuffs ⅹⅹⅧ:Inhibitors of nitric oxide production and new sesquiterpenes,zedoarofuran,4-epicurcumenol,neocurcumenol,gajutsulactones A and B,and zediarolides A and B,from zedoariae rhizoma[J].Chem.Pharm.Bull.2001,49,1558-1566.
[6]Hisashi M,Kiyofumi N,Toshio M,Masayuki Y.Inhibiroty effect and action mechanism of sesquiterpenes from zedoariae rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury[J].Bioorg.Med.Chem.Lett.1998,8,339-344.
[7]Hiroshi H,Yojiro S,et.al.Srtucture of procurcumenol[J].Chem.Pharm.Bull.1968,16,1605-1607.
[8]Yoshinori S,Yoshinori A,Mitsuaki K.et.al.Zedoarol.13-hydroxy germacrone and curzeone,three sesquiterpenoids from Curcuma zedoaria[J].Phytochemistry 1986,25,1351-1353.
[9]Isao K,Nobusuke K,et.al.Structure of a guaiane from Curcuma zedoaria[J].Phytochemistry 1985,24,1845-1847.
[10]Syu W J,Shen C C,et.al.Cytotoxicity of curcuminoids and some novel compounds from curcuma zedoaria[J].J.Nat.Prod.1998,61,1531-1534.
[11]Ichiro T,Ichiro Y,et.al.Guaine sesquiterpene lactones from Curcuma aeruginosa[J].Phytochemistry 1995,40,1197-2000.
[12]Ken K,Shinkichi N,et.al.Anti-babesial compounds from Curcuma zedoaria[J],planta med.2005,71,482-484.
[13]Cai Y.A new sesqueterpene compound curcumafuranol[J].Beijing YiKe Daxue XueBao,1998,30,49-52.
[14]Jiang D Q,Pu Q L,et.al.Studies on the chemical constituents of Curcuma kwangsiensis[J].Yaoxue XueBao 1989,24,357-359.
[15]Hiroshi H,Yojiro S.Hideji T.Tsunematsu T.Srtucture of curdione[J].Chem.Pharm.Bull.1966, 14,1310-1311.
[16]Hiroshi H,Konno C,et.al.Structure of dehydrocurdione,a sesquiterpenoid of Curcuma zedoaria[J].Chem.Pharm.Bull.1972,20,987-989.
[17]Tamiko O,Gao J F,et.al.Stereostructure of neocurdione isolated from Curcuma wenyujin[J].Shoyakugaku zashi 1986,40.352-354.
[18]Tamiko O,Gao J F,et.al.The absolute configuration and conformation of neocurdione[J].Chem.Pharm.Bull.1986,34,4435-4438.
[19]Kenzo H,Gao J F,et.al.A series of sesquiterpenes with a 7a-isopropyl side chain and related compounds isolated from Curcuma wenyujin[J].Chem.Pharm.Bull.1991,39,843-853.
[20]Minoru Y,Hirotaka S,et.al.The absolute sterostructure of(4S,5S)-(+)-germacrone 4,5-epoxide from Zedoariae rhizome cultivated in Yakushima island[J].Chem.Pharm.Bull.1984,32,2059-2062.
[21]Hirotaka S,Yoshio Y,Iwao M,Isao K.Absolute sterosteructure of furanogermacrene,biologically active sesquiterpene from zedoariae rhizoma[J].Heterocycles.1982.17,215-219.
[22]Gao J F,Xie J H.The sterostructure of wenjine and related(lS,10S),(4S,5S)-germacrone-l(10),4-diepoxide isolated from Curcuma wenyujin[J].Chem.Pharm.Bull.1989,37,233-236.
[23]Hiroshi H,Hideji Y,et.al.Srtucture of zederone[J].Chem.Pharm.Bull.1966,14,550-551.
[24]Hiroshi H,Shuji T,et.al,Srtucture of zederone[J].Chem.Pharm.Bull.1968,16,1081-1087.
[25]Sirat H M.,Jimil S,et.al.Sesquiterpenes from Curcuma aeruginosa[J],planta med.1998,64,584-585.
[26]Hiroshi H,Kunio A,et.al.Structure of furanodiene and isofuranogermacrene(curzerene)[J].Chem.Pharm.Bull.1970,18,752-755.
[27]Hiroshi H,Chohachi K,Kunio A,et.al.Sesquiterpenoids.XLVII.Structure,configuration,conformation,and thermal rearrangements of furanodienone,isofuranodienone,curzerenone,epicurzerenone,and pyrocurzerenone,sesquiterpenoids of Curcuma zedoaria[J].J.Chem.Soc.perkin I 1975,5,478-84.
[28]Shiobara Y,Asakawa Y,Mitsuaki,et.al.Curcumenone,curcumanolide A and curcumanolide B,three sesquiterpenoids from Curcuma zedoaria[J].Photochemistry 1985,24,2629-2633.
[29]Masayuki Y,Toshiyuki M,et.al.Absolute stereostructure of carabrane-type sesquiterpenes, curcumenone,4S-dihydrocurcumenone and curcarabranols A and B:vasorela-xant activity of zedoary sesquiterpenes[J].Chem.Pharin.Bull.1998,46.1186-1188.
[30]Hidashi M,Toshio M,et.al.Hepatoprotective constituents from zedoariae rhizoma:absolute stereostructures of three new carabrane-type sesqueterpenes,curcume-nolactones A.B.and C[J].Bioorg.Med.Chem.2001.9.909-916.
[31]Hidashi M,Toshio M,et.al.Absolute stereostructure of carabrane-type sesquetepene and vasorelaxant-active sespuiterpenes from zedoariae rhizoma[J].Tetrahedron 2001,57.8443-8453.
[32]Hideji L Fusayoshi H.Studies on the antitumor bisabolane sesquiterpenoids isolated from Curcuma xanthorrhiz.a[J].Chem.Pharm.Bull.1985.33.3488-3492.
[33]Uehara S,Ichiro Y,Koichi T,et.al.New bisabolane sesquiter-penoids from the rhizomes of Curcuma xanthorrhiza(zingiberaceae)[J].Chem.Pharm.Bull.1989,37.237-240.
[34]Uehara S,Yasuda I,et.al.New bisabolane sesquiterpenoids from the rhizomes of Curcuma xanthorrhiza(zingiberaceae)Ⅱ[J].Chem.Pharm.Bull.1990,38.261-263.
[35]Hiroshi H,Yojiro S,et.al.Srtucture of curcolone[J].Chem.Pharm.Bull.1967,15.1065-1066.
[36]Hikino H.Agatsuma K.Takemoto T.Structure of curzerenone,epicurzerenone,and isofuranogermacrene(curzerene)[J].Tetrahedron Lett.1968.24.2855-2858.
[37]Liu X Y.Lou Y,Qiu F.Chemical constituents of essential oil from Curcuma wenyujin.Shenyang Yaoke Daxue Xuebao.2007.24.682-686
[38]Seiichi I,Gao J F,et.al.The absolute configuration of curdione and the stereostructure of curcumalactone from Curcuma wenyujin[J].Chem.Pharm.Bull.1985,33.2179-2182.
[39]Masuda T,Isobe J,Jitoe A,et al.Antioxidative Curcuminoids from Rhizomes of Curcuma xanthorrhiza.Phytochemistry 1992.31.3645-3647.
[40]Suksamrarn A,Eiamong S.Piyachaturawat P,et al.Phenolic-diarylheptanoids from Curcuma xanthorrhiza.Phytochemistry 1994.36,505-1508.
[41]Claeson P,Panthong A,Tuchinda P,et a/.Three non-phenolic diarylheptanoids with anti-inflamatory activity from Curcuma xanthorrhiza.planta med.1993.59,451-454.
[42]Kiuchi F,Gato Y,Sugimoto N,et al.Nematocidal activity of turmeric:synergistic action of Curcuminoids.Chem.Pharm.Bull.1993.41.1640-1643.
[43]窦桂荣,秦进喜,只达石,等.榄香烯对脑神经胶质细胞瘤抑制的实验研究[J].天津医科大学学报,1998,4,9-11.
[44]范钰,林庚金,钱立平,等.榄香烯乳对胃癌SGC-7091细胞株端粒酶活性及细胞凋亡的影响[J].旦学报(医学科学版),2001,28,5-8.
[45]施广霞,郭连英,刘金友,等.抗肿瘤的实验研究Ⅱ:β-榄香烯抗Ca761-86乳腺癌的实验研究[J].大连医学院学报,1994,16,161-164.
[46]钱军,杨爱珍,等.榄香烯乳对体外培养人肺癌细胞株超微结构的影响[J].临床肿瘤学杂志,1997,2,49-51.
[47]施广霞,于丽华,刘金友,等.β-榄香烯抗肿瘤作用的实验研究Ⅰ:榄香烯体外对L615白血病细胞直接作用的实验研究[J].大连医学院学报,1994,16,137-138.
[48]许洪霞.温莪术抗肿瘤有效成份的研究[J].中草药通讯,1979,10,13-15.
[49]刘君怡.防治肿瘤的中药-莪术[J].中草药,1996,27,572-574.
[50]杨骅,王仙平,郁琳琳,等.榄香烯抗癌作用与诱发肿瘤细胞凋亡[J].中华肿瘤杂志,1996,18,169-172.
[51]邹丽娟,李杰,于丽敏,等.β-榄香烯抗癌作用与诱发肿瘤细胞凋亡的研究[J].大连医科大学学报,1998,20,9-11.
[52]袁静,等.榄香烯诱导人白血病K_(562)细胞凋亡及调控bcl-2蛋白的表达[J].中国药理学报,199920,103-105.
[53]邹丽娟,刘伟先,于丽敏等.β-榄香烯诱导K_(562)白血病细胞凋亡[J].中华肿瘤杂志,2001,23,196-198.
[54]陈龙邦,等.β-榄香烯诱导小鼠黑色素瘤B_(16)细胞凋亡的研究[J].金陵医学院学报,1999,12,48-51.
[55]谭敏,宾晓农,吴万垠,等.莪术油对小鼠肝癌细胞原位凋亡的影响[J].中西结合肝病杂志,2002,12,290-291.
[56]王娟,王顺启,倪虹,等.莪术挥发油抑制人肝癌细胞株SMMC-7721生长的实验研究[J].天津中医药,2003,20,48-51.
[57]马东礼,童善庆.榄香烯对HeLa细胞端粒酶催化亚单位基因表达的作用[J].中国癌症杂志,2001,11,9-13.
[58]宋利琼,张昌菊.莪术油联合干扰素对鼠宫颈癌端粒酶活性和细胞凋亡影响的研究[J].实用医学进修杂志,2005,33,31-35.
[59]Sakamoto K.Synergistic efects of thearubigin and genistein on human prostate rumor cella(PC-3)growth via cell cycle arrest[J].Cancer Lett.,2000,151.103-109.
[60]吴万垠,徐勤.莪术油对小鼠肝癌细胞DNA作用的图像分析[J].中西医结合肝病杂志,1999,9,18-20.
[61]徐立春,边可君.天然药物莪术醇抑制肿瘤细胞生长及RNA合成影响的初步研究[J].肿瘤,2005,25,570-572.
[62]钱军,等.榄香烯乳逆转人肺癌细胞的实验研究[J].肿瘤防治,1996,23,299-301.
[63]胡守友,等.β-榄香烯对小鼠黑色素瘤细胞的诱导分化作用[J].南京大学学报(自然科学版),1998,34,550-552.
[64]陈剑群,吴克俭,费素娟.榄香烯乳注射液治疗中晚期消化系肿瘤前后T淋巴细胞亚群的动态观察[J].肿瘤临床,1996.23,299-301.
[65]卜长武,王东荣,郭文来,王艳,李萍,赵秀玲.莪术对小白鼠免疫功能的影响[J].中国中医药信息杂志,1997,4,29-31.
[66]崔秀云,李德山.榄香烯对RNA聚合酶活性的抑制及与DNA的结合[J].中国药理学报,1991,7,228-231.
[67]陈红,邓德宁,范茜.莪术醇及莪术醇磷酸酯单钠对Ehrlich腹水癌细胞电位和钾离子通道的影响[J].首都医学院学报,1989,10,23-25.
[68]阎田玉,郑企静,周光延,等.莪术油注射液治疗小儿呼吸道合胞病毒肺炎及其作用原理的研究[J].中国中西医结合杂志,1992,12,711-715.
[69]李芳芬.莪术油注射液加青霉索治疗上呼吸道感染125例临床分析[J].中医药学报,1993,3,12-13.
[70]毛梅仙.莪术油注射液治疗小儿病毒性肠炎[J].Herald of Medicine,2002,21,298-291.
[71]夏治群,董启.莪术油治疗小儿病毒性肠炎疗效观察[J].中医药信息,1999,5,37-39.
[72]王培养.莪术油注射液治疗小儿手足口病疗效观察[J].浙江中西医结合杂志,2003,13,437-439.
[73]诸锦春.莪术油治疗小儿呼吸道感染的疗效观察[J].儿科药学杂志,2003,9,52-54.
[74]程国平,刘明海.莪术油治疗流行性腮腺炎的临床对照实验[J].药物流行病学杂志,1999,8,203-204.
[75]吴建敏.莪术油葡萄糖注射液治疗急性病毒性脑炎疗效观察[J].海峡药学,2003,15,49-50.
[76]魏玉平,骆志成.莪术挥发油体外抗念珠菌活性的研究[J].中国麻风皮肤病杂志,2005,21, 524-526.
[77]毛春芹,谢辉等.术炮制品的抗血小板聚集及抗凝血作用[J].中药材,2000,23,212-213.
[78]唐泽耀,宗成国.林原莪术醇的活血化瘀活性实验研究[J].中药药理与临床,2003,19,15-15.
[79]陆群,谢梅林,等.榄香烯乳抑制大鼠血小板聚集的机理研究[J].苏州医学院学报,1996,16,844-846.
[80]魏兰福,邹百仓,等.莪术对大鼠胃动力影响的实验研究[J].湖南中医杂志,2003,19,58-59.
[81]魏兰福,邹百仓,等.莪术对实验大鼠胃动力的影响[J].上海中医药杂志,2003,37,46-48.
[82]魏兰福,邹百仓,等.莪术对实验性功能性消化不良大鼠胃排空的影响[J].南京医科大学学报(自然科学皈),2003,23,350-352.
[83]饶伟文.癌胚共性与抗生育中草药的抗肿瘤作用[J].中草药,1997,28,178-180.
[84]李希新,张恒齐.论妊娠禁忌药在妊娠期的应用[J].山东中医杂志,1999,18,368-70.
[85]李莲姬,韩春姬.莪术对老年小鼠学习记忆与脂质过氧化作用的影响[J].中药材,1998,21,522-523.
[86]黄可新,潘建春.温莪术丙酮部分抗动物惊厥作用的研究[J].中国药理学会通讯,2000,17,56-56.
[87]宋智琦,韩世新.莪术油霜剂外用治疗银屑病的药效学及作用机制研究[J].中国皮肤性病学杂志,2001,15,301-303.
[88]韩铭钧,等.油性中药抗癌剂OCC肝动脉栓塞治疗肝癌84例3年随访报告[J].临床放射学杂志,1998,17,112-114.
[89]谭立欣,等.抗癌新药榄香烯乳治疗晚期患者肿瘤的临床评价[J].中国中药信息杂志,1997,4,11-12.
[90]汪伟民,等.中药莪术油对小鼠Lewis肺癌抑制作用的实验研究[J].中国中医药科技,2003,10,353-354.
[91]糜福顺,等.莪术油对肺腺癌(LA-795)的放射增敏作用[J].中华放射医学与防护杂志,1992,6,405-407.
[92]王新生,王成芬,王利燕.莪术油葡萄糖注射液治疗病毒性肺炎的治疗观察[K].中医药研究,2000,16,16-19.
[93]张穗,黄又新,高素军.莪术油注射液治疗小儿急性甲型病毒性肝炎39例[J].中西医结合肝病杂志,1994,4,36-39.
[94]杨卫民,雷林东,张辉,等.莪术油滴眼液治疗单疱疹性角膜炎的临床观察[J].眼科研究, 2000,18,192.
[95]庞国明,等.常用药物新用途临床大全[M].北京.中国医药出版社,1993,635.
[96]U.S.Dispensatory[M].24ED,1947:1652.
[97]任王华.莪术油胶丸治疗消化性溃疡的临床观察[J].实用中西医结合杂志。1990,3,164-165.
[98]宋智琦,林煦然.外用莪术油霜剂治疗银屑病[J].华皮肤科杂志,1998,31,124-127.
[99]戴兴冬,王德玲,常宝月.莪术油治疗过敏性紫癜72例[J].吉林中医药,1998,18,37-39.
[1]Syu W J,Shen C C.Don M J.et.al.Cytotoxicity of Curcuminoids and Some Novel Compounds from Curcuma zedoaria[J].J.Nat.Prod.1998,61,1531-1534.
[2]Wang Q,Mu Q,Shibano M.et.al.Eremophilane Sesquiterpenes from Ligularia macrophylla[J].J.Nat.Prod.2007,70,1259-1262.
[3]Wu B.He S,Wu X D,et.al.New tyrosinase inhibitory sesquiterpenes from Chloranthus henryi[J].Chem.Biodivers.2008,5,1298-1303.
[4]Yang S P,Zhang C R,Chen H D,et.al.Sesquiterpenoids from Chloranthus spicatus(Thunb.)Makino[J].Chinese J.Chem.2007,25,1892-1895.
[5]Zdero C,Bohlmann F,Haegi L,et.al.Eudesmanolides and other constituents from Cratystylis conocephala[J].Phytochemistry 1988,27,865-868.
[6]Boriky D,Berrada M,Talbi M,et.al.Eudesmanolides from Artemisia herba-alba[J].Phytochemistry 1996,43,309-311
[7]Takano I,Yasuda I,Takeya K,et.al.Guaiane sesquiterpene lactones from Curcuma aeruginosa[J].Phytochemistry 1995,40,1197-1200.
[8]Kuroyanagi M,Ueno A,Ujiie K,et.al.Structures of sesquiterpenes from Curcuma aromatica Salisb[J].Chem.Pharm.Bull.1987,35,53-59.
[9]Masuda T,Jitoe A,Nakatani N.Structure of aerugidiol,a new bridge-head oxygenated guaiane sesquiterpene[J].Chem.Lett.1991,9,1625-1628.
[10]Snatzke G.Circular dichroism.Ⅷ.Modification of the octant rule for α,β-unsaturated ketones;theory[J].Tetrahedron 1965,21,413-419.
[11]Snatzke G,Circular dichroism.X.Modification of the octant rule for α,β-unsaturated ketones;cisoid enones,dienones,and aryl ketones[J].Tetrahedron 1965,21,421-438.
[12]Snatzke G,Circular dichroism.Ⅸ.Modification of the octant rule for α,β-unsaturated ketones;transoid enones[J].Tetrahedron 1965,21,438-448.
[13]Zhu H J,Ren J,Pittman C U,Jr.Matrix Model to Predict Specific Optical Rotations of Acyclic Chiral Molecules[J].Tetrahedron 2007,63,2292-2314.
[14]Zhu H J,Modern Organic Stereochemistry[M],Science Press,Beijing,2009,Chapter 1,p.16-38.
[15]Kristina J S.Karsten S,Jasmin J,et.al.Sipandinolide:a butenolide including a novel type of carbon skeleton from Siparuna andina[J].Planta Med.2000,66,384-385.
[16]Giang P M,Son P T.Matsunami K.et.al.New sesquiterpenoids from Curcuma aff.aeruginosa Roxb[J].Heterocycle 2007.74,977-981.
[17]Watson W H,Kashyap R P.Conformations of germacra-l(10).4-dien-6,12-olides and-8.12-olides.A comparison of x-ray diffraction,NMR.and molecular mechanics derived conformations[J].J.Org.Chem.1986.51,2521-2524.
[18]Kotsos M P,Aligiannis N,Myrianthopoulos V,et.al.Sesquiterpene Lactones from Staehelina fruticosa[J].J.Nat.Prod.2008.71.847-851.
[19]Riingeler P.Brecht V,Tamayo-Castillo G,et.al.Germacranolides from Mikania guaco[J].Phytochemistry 2001.56,475-489.
[20]Tashkhodzhaev B,Sham'yanov I D,Izbosarov M B.et.al.Crystal and molecular structure of 13-diethanolamino-deacetyllaurenobiolide.Macrocycle conformation in linear germacrolides[J].Chem.Nat.Compd.2004.40.552-556.
[21]Lange G L,Lee M.Carbon-13 NMR determination of the configuration of methyl-substituted double bonds in medium-and large-ring terpenoids[J].Magn.Reson.Chem.1986.24.656-658.
[22]Chen Z L,Cao W Y,Zhou G X.A sesquiterpene lactam from Artractylodes macrocephala[S].Phytochemistry 1997.45.765-767.
[23]Kuroyanagi M,Ueno A.Koyama K.et.al.Structures of sesquiterpenes of Curcuma aromatica Salisb[J].Ⅱ.Studies on minor sesquiterpenes.Chem.Pharm.Bull.1990,38,55-8.
[24]Ohshiro M,Kuroyanagi M,et.al.Structures of sesquiterpenes from Curcuma longa[J].Phytochemistry 1990.29,2201-2205.
[25]Kasahara K,Nomura S.Subeki,et.al.Anti-babesial compounds from Curcuma zedoaria[J].Planta Med.2005.71,482-484.
[26]Matsuda H,Morikawa T,Toguchida I,et.al.Medicinal foodstuffs.XXVIII.Inhibitors of nitric oxide production and new sesquiterpenes,zedoarofuran,4-epicurcumenol,neocurcumenol,gajutsulactones A and B.and zedoarolides A and B,from Zedoariae Rhizoma[J].Chem.Pharm.Bull.2001,49,1558-1566.
[27]Shiobara Y,Iwata T,Kodama M,et.al.Biomimetic transformation of dehydrocurdione into curcumenol and isocurcumenol and their stereochemistries[J].Tetrahedron Lett.1985.26,913-916.
[28]Hiroshi H,Kangi M.et.al.Srtucture of curcumol[J].Chem.Pharm.Bull.1966,14:1241-1249.
[29]Yoshikawa M,Yamaguchi S,Matsuda H,et.al.Crude drugs from aquatic plants.Ⅳ.on the constituents of alismatis rhizome.(2).Stereostructures of bioactive sesquiterpenes alismol,alismoxide,orientalols A,B,and C,from Chinese alismatic rhizome[J].Chem.Pharm.Bull.1994,42,1813-1816.
[30]Oshima Y,Iwakawa T,Hikino H.Alismol and alismoxide,sesquiterpenoids of alzsma rhizomes[J].Phytochemistry,1983,22,183-185.
[31]Seiichi I,Gao J E et.al.Stereostructure of curdione[J].Chem.Pharm.Bull.1985,33:1323-1326
[32]Yoshihara M,Shibuya H,et.al.The absolute sterostructure of(4S,5S)-(+)- germacrone 4,5-epoxide from Zedoariae rhizome cultivated in Yakushima island[J].Chem.Pharm.Bull.1984,32,2059-2062.
[33]Harimaya K,Gao J F,Ohkura T.et.al.A series of sesquiterpenes with a 7-isopropyl side chain and related compounds isolated from Curcuma wenyujin[J].Chem.Pharm.Bull.1991,39.843-853.
[34]Matsuda H,Morikawa T,Ninomiya K,et.al.Absolute stereostructure of carabrane-type sesquiterpene and vasorelaxant-active sesquiterpenes from Zedoariae Rhizoma[J].Tetrahedron 2001,57,8443-8453.
[35]Friedrich D,Bohlmann F.Total synthesis of various elemanolides[J].Tetrahedron 1988,44,1369-1392.
[36]Kikuzaki H,Nakatani N.Cyclic diarylheptanoids from rhizomes of zingiber officinale[J].Phytochemistry 1996,43,273-277.
[37]Yi J H,Chen Y,et.al.Studies on chemical constituents of the tubers of curcuma longa[J].Natural Product Research and Development 2003,15,98-100.
[38]Chiang Y M,Liu H K.Cytotoxic constituents of the leaves of Calocedrus fomosana[J].Journal of the Chinese Chemical Society.2003,50(1):161-166.
[39]于德全,杨峻山,等.分析化学手册第二版第七分册[M],核磁共振波谱分析,化学工业出版社,822
[1]Kageura T,Matsuda H,Morikawa T,et al.Inhibitors from Rhubarb on Lipopolysaccharide-Induced Nitric Oxide Production in Macrophages:Structural Requirements of Stilbenes for the Activity.Bioorg.Med.Chem.2001,9,1887-1893.
[2]归莉琼,魏东芝.NO:一种重要的生物信使分子.生命科学 1998,10,188-190.
[3]郑永晨,杨贵贞.一氧化氮与巨噬细胞的免疫调节.国外医学免疫学分册1995,4,204-206.
[4]胡章颜.一氧化氮与细胞凋亡的研究进展.江西医学院学报2005,45,176-178.
[5]王媛,柏树令.一氧化氮合酶与主动脉瘤.解剖科学进展2005,11,268-272.
[6]Hidashi M,Toshio M,et.al.Medicinal foodstuffs ⅩⅩⅧ:Inhibitors of nitric oxide production and new sesquiterpenes,zedoarofuran,4-epicurcumenol,neocurcumenol,gajutsulactones A and B,and zediarolides A and B,from zedoariae rhizoma[J].Chem.Pharm.Bull.2001,49,1558-1566.
[7]Hidashi M,Toshio M,et.al.Absolute stereostructure of carabrane-type sesquetepene and vasorelaxant-active sespuiterpenes from zedoariae rhizoma[J].Tetrahedron 2001,57,8443-8453.
[8]Dirsch V M,Stuppner H,Vollmar A M.The Griess assay:suitable for a bioguided fractionation of anti-inflammatory plant extracts.Planta Med 1998,64,423-426
[1]Guerra M C,Speronil Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin Antioxidant properties and effects on rat liver CYP-catalysed drug metabolism[J],Pharmacology letters 2000,67,2997-3001.
[2]左风,严梅桢,周钟鸣.肠道菌群对中药有效成分代谢作用的研究[J].中国中药杂志2002,27,568-571.
[3]孙艳,李雪驼,殷素兰.肠道内微生态环境对中草药体内代谢的影响[J].中草药2001,32,375-378.
[4]刘明杰,林琳,王钊.肠道菌群对天然药物代谢的研究进展Ⅰ[J].中国现代应用药学2001,18,90-93.
[5]刘明杰,林琳,王钊.肠道菌群对天然药物代谢的研究进展Ⅱ[J].中国现代应用药学2001,18,257-259.
[6]严梅桢.人肠道菌对柴胡皂甙的代谢[J].国外医学中医中药分册2001,3,156-159.
[7]钟大放.液相色谱-质谱联用法在药物研究中的应用[J].世界科学技术-中药现代化2003,5,44-47.
[8]李慧义,罗淑荣.液相色谱-质谱联用及其在药物代谢研究中的应用[J].国外医学--药学分册1997,24,257-263.
[9]杨春,司伊康.药物代谢研究中的核磁共振技术[J].药物分析杂志1999,19,422-26.
[10]丁黎,张正行,安登魁.药物代谢物结构研究中的色谱-光谱联用技术[J].药学进展2000,24,200-204.
[11]梁剑平,卫增泉,张力.稳定同位素在药物动力学研究中的新进展[J].原子核物理评论1998,15,110-114.
[12]孙晖,吴泽明.中药及其复方的体内代谢研究现状与未来发展[J].世界科学技术-中药现代化2006,8,1-6
[13]朱大元,黄宝山,陈仲良,等,人体代谢青蒿素转化物的分离和鉴定[J].中国药理学报1983,4,194-197.
[14]李志,王堃,陈玉仁,吴秀英,苏成业.大鼠胆汁中β-榄香烯代谢产物的研究[J].药学学报2000,35,829-831.
[15]陈昕,周秋丽,王本祥.人参皂苷Rb1在大鼠肠内菌代谢物吸收入血成分的研究[J].药学 学报1999,34,410-412.
[16]陈昕,周秋丽,王本祥.人参皂苷Rb1在大鼠肠内菌代谢物吸收入血成分的研究[J].药学学报1999,34,481-483.
[17]Cui L,Qiu F,Yao XS.Isolation and identification of seven glucuronide conjugates of andrographolide in human urine.[J].Drug Metab.Dispos.2005,33,555-562.
[18]He XJ,Qiu F,Yao XS.identification of a rare sulfonic acid metabolite of andrographolide in rats [J].Drug Metab.Dispos.2003,31,983-985.
[19]彭仕华,崔燕岩,周同惠.氯代正丁苯酞在大鼠肝微粒体中的代谢研究[J].药学学报1996,31,780-784.
[20]Qiu F,Zhu ZY,Kang N,et al.Isolation and identification of urinary metabolites of berberine in rats and humans.[J].Drug Metab.Dispos.2008,36,2159-2165.
[21]Cheng WM,Qiu F,Yao XS.Three major urinary metabolites of sinomenine in rats[J].J Asian Nat.Prod.Res.2007,9,山版 13-18.
[22]江骥,姜国辉,叶云鹏,等.川芎嗪的体内代谢[J].中国医学科学院学报,1993,15,79.
[23]张文江,周同惠.海南粗榧新碱衍生物HH07A在大鼠体内的代谢转化研究[J].药学学报,1998,33,212-216.
[24]林沐彬,张伟,赵学文,等.粉防己碱在体内的代谢转化[J].药学学报1982,7,728-730.
[25]邱峰,陈英杰,鹿野美弘,等.淫羊藿苷在大鼠体内的代谢[J].药学学报1999,34,222-226.
[26]Qiu F,Xia HJ,Zhang TY,Di X,et al.Two Major Urinary Metabolites of Scutellarin in Rats[J].Planta Med.2007,73,363-365.
[27]张军,杨克文.葛根素在大鼠尿和胆汁中的代谢物[J].国外医学-中医中药分册1996,18,46.
[28]薛明,崔颖,汪汉卿,罗永江,张彬,周宗田。隐丹参酮及其代谢物在猪体内的药代动力学研究[J].药学学报1999,34,81-84.
[29]薛廷民,番泻苷C在小鼠体内的代谢活化-与蒽酮的协同作用[J].国外医药-植物药分册1993,8,84-85.
[30]游金辉,谭天秩,匡安仁,等.~3H-天麻苷元和~3H-天麻素在小鼠体内的分布和代谢[J].华西医科大学学报1994,25,325-328.
[31]Zeng YC,Qiu F,Liu Y,Qu GX,Yao XS.Isolation and Identification of Phase 1 Metabolites of Demethoxycurcumin in Rats[J].Drug Metab.Dispos.2007,35,1564-1573.
[32]薛社菁,等,医学研究通报,1988,7,26-29.
[33]Feng Qiu,Kenichi Komatsu.et al.Pharmacokinetical Study of Mulberroside A and Its Metabolites in Rat[J].Biol.Pharm.Bull.1996,19,1463-1467.
[34]XIA HJ,Qiu E Zhu S,et al.Isolation and Identification of Ten Metabolites of Breviscapine in Rat Urine[J].Biol.Pharm.Bull.2007,30,1308-1316.
[35]杨异卉,朱志勇,陈丽霞,邱峰.人口服黄连水煎液尿中化学成分的分离鉴定[A].2008年中国药学会学术年会暨第八界全国中药和天然药物学术研讨会.
[36]雷厉,宋志宏,李寅增,等.管花肉从蓉苯乙醇总苷在狗胃肠道内的生物转化[J].药学学报2001,36,432-435.
[37]师少军,陈汇,曾繁典.中药复方药物代谢动力学研究方法及展望[J].中国临床药理学杂志2001,17,235-238.
[38]吴立军,王本祥.参附汤体内代谢化学成分的初步研究[J].沈阳药科大学学报 2001,18,23-26.
[39]苏成业,刘金友,许洪霞.~3H-莪术醇在正常大鼠及肿瘤小鼠体内的代谢研究[J].药学学报,1980,15,257-262.
[1]Zhang H,Qiu F,Yao XS,QU GX.Microbial transformation of curcumol by Cunninghamella blakesleana[J].J Asian Nat Prod Res.2007,9,311-9.
[2]张卉,莪术醇的微生物转化及大鼠体内代谢产物研究,沈阳药科大学博士论文,2005,pp 64-73.
[1]费健康,孔宪章.莪术醇注射液处方的改进[J].药学通报.1980,15,491-92.
[2]游金辉,谭天秩,匡安仁,等.~3H-天麻苷元和~3H-天麻素在小鼠体内的分布和代谢[J].华西医科大学学报.1994,25,325-328.
[1]张卉,莪术醇的微生物转化及大鼠体内代谢产物研究,沈阳药科大学博士论文,2005,pp24-30.
[2]Hiroshi H.Kangi M.et.al.Structure of curcumol[J].Chem.Pharm.Bull.1965,13,1484-1485.
[3]Hiroshi H,Kangi M,et.al.Srtucture of curcumol[J].Chem.Pharm.Bull.1966,14.1241-1249.
[4]Hiroshi H.Yojiro S,et.al.Structure of curcumenol[J].Chem.Pharm.Bull.1968,16,39-42.
[5]Hidashi M,Toshio M,et.al.Medicinal foodstuffs ⅹⅹⅧ:Inhibitors of nitric oxide production and new sesquiterpenes,zedoarofuran,4-epicurcumenol,neocurcumenol,gajutsulactones A and B,and zediarolides A and B,from zedoariae rhizoma[J].Chem.Pharm.Bull.2001,49,1558-1566.
[6]Hisashi M,Kiyofumi N,Toshio M,Masayuki Y.Inhibiroty effect and action mechanism of sesquiterpenes from zedoariae rhizoma on D-galactosamine/lipopolysaccharide-induced liver injury[J].Bioorg.Med.Chem.Lett.1998,8,339-344.
[7]Hiroshi H,Yojiro S,et.al.Srtucture of procurcumenol[J].Chem.Pharm.Bull.1968,16,1605-1607.
[8]Yoshinori S,Yoshinori A,Mitsuaki K.et.al.Zedoarol.13-hydroxy germacrone and curzeone,three sesquiterpenoids from Curcuma zedoaria[J].Phytochemistry 1986,25,1351-1353.
[9]Isao K,Nobusuke K,et.al.Structure of a guaiane from Curcuma zedoaria[J].Phytochemistry 1985,24,1845-1847.
[10]Syu W J,Shen C C,et.al.Cytotoxicity of curcuminoids and some novel compounds from curcuma zedoaria[J].J.Nat.Prod.1998,61,1531-1534.
[11]Ichiro T,Ichiro Y,et.al.Guaine sesquiterpene lactones from Curcuma aeruginosa[J].Phytochemistry 1995,40,1197-2000.
[12]Ken K,Shinkichi N,et.al.Anti-babesial compounds from Curcuma zedoaria[J],planta med.2005,71,482-484.
[13]Cai Y.A new sesqueterpene compound curcumafuranol[J].Beijing YiKe Daxue XueBao,1998,30,49-52.
[14]Jiang D Q,Pu Q L,et.al.Studies on the chemical constituents of Curcuma kwangsiensis[J].Yaoxue XueBao 1989,24,357-359.
[15]Hiroshi H,Yojiro S.Hideji T.Tsunematsu T.Srtucture of curdione[J].Chem.Pharm.Bull.1966, 14,1310-1311.
[16]Hiroshi H,Konno C,et.al.Structure of dehydrocurdione,a sesquiterpenoid of Curcuma zedoaria[J].Chem.Pharm.Bull.1972,20,987-989.
[17]Tamiko O,Gao J F,et.al.Stereostructure of neocurdione isolated from Curcuma wenyujin[J].Shoyakugaku zashi 1986,40.352-354.
[18]Tamiko O,Gao J F,et.al.The absolute configuration and conformation of neocurdione[J].Chem.Pharm.Bull.1986,34,4435-4438.
[19]Kenzo H,Gao J F,et.al.A series of sesquiterpenes with a 7a-isopropyl side chain and related compounds isolated from Curcuma wenyujin[J].Chem.Pharm.Bull.1991,39,843-853.
[20]Minoru Y,Hirotaka S,et.al.The absolute sterostructure of(4S,5S)-(+)-germacrone 4,5-epoxide from Zedoariae rhizome cultivated in Yakushima island[J].Chem.Pharm.Bull.1984,32,2059-2062.
[21]Hirotaka S,Yoshio Y,Iwao M,Isao K.Absolute sterosteructure of furanogermacrene,biologically active sesquiterpene from zedoariae rhizoma[J].Heterocycles.1982.17,215-219.
[22]Gao J F,Xie J H.The sterostructure of wenjine and related(lS,10S),(4S,5S)-germacrone-l(10),4-diepoxide isolated from Curcuma wenyujin[J].Chem.Pharm.Bull.1989,37,233-236.
[23]Hiroshi H,Hideji Y,et.al.Srtucture of zederone[J].Chem.Pharm.Bull.1966,14,550-551.
[24]Hiroshi H,Shuji T,et.al,Srtucture of zederone[J].Chem.Pharm.Bull.1968,16,1081-1087.
[25]Sirat H M.,Jimil S,et.al.Sesquiterpenes from Curcuma aeruginosa[J],planta med.1998,64,584-585.
[26]Hiroshi H,Kunio A,et.al.Structure of furanodiene and isofuranogermacrene(curzerene)[J].Chem.Pharm.Bull.1970,18,752-755.
[27]Hiroshi H,Chohachi K,Kunio A,et.al.Sesquiterpenoids.XLVII.Structure,configuration,conformation,and thermal rearrangements of furanodienone,isofuranodienone,curzerenone,epicurzerenone,and pyrocurzerenone,sesquiterpenoids of Curcuma zedoaria[J].J.Chem.Soc.perkin I 1975,5,478-84.
[28]Shiobara Y,Asakawa Y,Mitsuaki,et.al.Curcumenone,curcumanolide A and curcumanolide B,three sesquiterpenoids from Curcuma zedoaria[J].Photochemistry 1985,24,2629-2633.
[29]Masayuki Y,Toshiyuki M,et.al.Absolute stereostructure of carabrane-type sesquiterpenes, curcumenone,4S-dihydrocurcumenone and curcarabranols A and B:vasorela-xant activity of zedoary sesquiterpenes[J].Chem.Pharin.Bull.1998,46.1186-1188.
[30]Hidashi M,Toshio M,et.al.Hepatoprotective constituents from zedoariae rhizoma:absolute stereostructures of three new carabrane-type sesqueterpenes,curcume-nolactones A.B.and C[J].Bioorg.Med.Chem.2001.9.909-916.
[31]Hidashi M,Toshio M,et.al.Absolute stereostructure of carabrane-type sesquetepene and vasorelaxant-active sespuiterpenes from zedoariae rhizoma[J].Tetrahedron 2001,57.8443-8453.
[32]Hideji L Fusayoshi H.Studies on the antitumor bisabolane sesquiterpenoids isolated from Curcuma xanthorrhiz.a[J].Chem.Pharm.Bull.1985.33.3488-3492.
[33]Uehara S,Ichiro Y,Koichi T,et.al.New bisabolane sesquiter-penoids from the rhizomes of Curcuma xanthorrhiza(zingiberaceae)[J].Chem.Pharm.Bull.1989,37.237-240.
[34]Uehara S,Yasuda I,et.al.New bisabolane sesquiterpenoids from the rhizomes of Curcuma xanthorrhiza(zingiberaceae)Ⅱ[J].Chem.Pharm.Bull.1990,38.261-263.
[35]Hiroshi H,Yojiro S,et.al.Srtucture of curcolone[J].Chem.Pharm.Bull.1967,15.1065-1066.
[36]Hikino H.Agatsuma K.Takemoto T.Structure of curzerenone,epicurzerenone,and isofuranogermacrene(curzerene)[J].Tetrahedron Lett.1968.24.2855-2858.
[37]Liu X Y.Lou Y,Qiu F.Chemical constituents of essential oil from Curcuma wenyujin.Shenyang Yaoke Daxue Xuebao.2007.24.682-686
[38]Seiichi I,Gao J F,et.al.The absolute configuration of curdione and the stereostructure of curcumalactone from Curcuma wenyujin[J].Chem.Pharm.Bull.1985,33.2179-2182.
[39]Masuda T,Isobe J,Jitoe A,et al.Antioxidative Curcuminoids from Rhizomes of Curcuma xanthorrhiza.Phytochemistry 1992.31.3645-3647.
[40]Suksamrarn A,Eiamong S.Piyachaturawat P,et al.Phenolic-diarylheptanoids from Curcuma xanthorrhiza.Phytochemistry 1994.36,505-1508.
[41]Claeson P,Panthong A,Tuchinda P,et a/.Three non-phenolic diarylheptanoids with anti-inflamatory activity from Curcuma xanthorrhiza.planta med.1993.59,451-454.
[42]Kiuchi F,Gato Y,Sugimoto N,et al.Nematocidal activity of turmeric:synergistic action of Curcuminoids.Chem.Pharm.Bull.1993.41.1640-1643.
[43]窦桂荣,秦进喜,只达石,等.榄香烯对脑神经胶质细胞瘤抑制的实验研究[J].天津医科大学学报,1998,4,9-11.
[44]范钰,林庚金,钱立平,等.榄香烯乳对胃癌SGC-7091细胞株端粒酶活性及细胞凋亡的影响[J].旦学报(医学科学版),2001,28,5-8.
[45]施广霞,郭连英,刘金友,等.抗肿瘤的实验研究Ⅱ:β-榄香烯抗Ca761-86乳腺癌的实验研究[J].大连医学院学报,1994,16,161-164.
[46]钱军,杨爱珍,等.榄香烯乳对体外培养人肺癌细胞株超微结构的影响[J].临床肿瘤学杂志,1997,2,49-51.
[47]施广霞,于丽华,刘金友,等.β-榄香烯抗肿瘤作用的实验研究Ⅰ:榄香烯体外对L615白血病细胞直接作用的实验研究[J].大连医学院学报,1994,16,137-138.
[48]许洪霞.温莪术抗肿瘤有效成份的研究[J].中草药通讯,1979,10,13-15.
[49]刘君怡.防治肿瘤的中药-莪术[J].中草药,1996,27,572-574.
[50]杨骅,王仙平,郁琳琳,等.榄香烯抗癌作用与诱发肿瘤细胞凋亡[J].中华肿瘤杂志,1996,18,169-172.
[51]邹丽娟,李杰,于丽敏,等.β-榄香烯抗癌作用与诱发肿瘤细胞凋亡的研究[J].大连医科大学学报,1998,20,9-11.
[52]袁静,等.榄香烯诱导人白血病K_(562)细胞凋亡及调控bcl-2蛋白的表达[J].中国药理学报,199920,103-105.
[53]邹丽娟,刘伟先,于丽敏等.β-榄香烯诱导K_(562)白血病细胞凋亡[J].中华肿瘤杂志,2001,23,196-198.
[54]陈龙邦,等.β-榄香烯诱导小鼠黑色素瘤B_(16)细胞凋亡的研究[J].金陵医学院学报,1999,12,48-51.
[55]谭敏,宾晓农,吴万垠,等.莪术油对小鼠肝癌细胞原位凋亡的影响[J].中西结合肝病杂志,2002,12,290-291.
[56]王娟,王顺启,倪虹,等.莪术挥发油抑制人肝癌细胞株SMMC-7721生长的实验研究[J].天津中医药,2003,20,48-51.
[57]马东礼,童善庆.榄香烯对HeLa细胞端粒酶催化亚单位基因表达的作用[J].中国癌症杂志,2001,11,9-13.
[58]宋利琼,张昌菊.莪术油联合干扰素对鼠宫颈癌端粒酶活性和细胞凋亡影响的研究[J].实用医学进修杂志,2005,33,31-35.
[59]Sakamoto K.Synergistic efects of thearubigin and genistein on human prostate rumor cella(PC-3)growth via cell cycle arrest[J].Cancer Lett.,2000,151.103-109.
[60]吴万垠,徐勤.莪术油对小鼠肝癌细胞DNA作用的图像分析[J].中西医结合肝病杂志,1999,9,18-20.
[61]徐立春,边可君.天然药物莪术醇抑制肿瘤细胞生长及RNA合成影响的初步研究[J].肿瘤,2005,25,570-572.
[62]钱军,等.榄香烯乳逆转人肺癌细胞的实验研究[J].肿瘤防治,1996,23,299-301.
[63]胡守友,等.β-榄香烯对小鼠黑色素瘤细胞的诱导分化作用[J].南京大学学报(自然科学版),1998,34,550-552.
[64]陈剑群,吴克俭,费素娟.榄香烯乳注射液治疗中晚期消化系肿瘤前后T淋巴细胞亚群的动态观察[J].肿瘤临床,1996.23,299-301.
[65]卜长武,王东荣,郭文来,王艳,李萍,赵秀玲.莪术对小白鼠免疫功能的影响[J].中国中医药信息杂志,1997,4,29-31.
[66]崔秀云,李德山.榄香烯对RNA聚合酶活性的抑制及与DNA的结合[J].中国药理学报,1991,7,228-231.
[67]陈红,邓德宁,范茜.莪术醇及莪术醇磷酸酯单钠对Ehrlich腹水癌细胞电位和钾离子通道的影响[J].首都医学院学报,1989,10,23-25.
[68]阎田玉,郑企静,周光延,等.莪术油注射液治疗小儿呼吸道合胞病毒肺炎及其作用原理的研究[J].中国中西医结合杂志,1992,12,711-715.
[69]李芳芬.莪术油注射液加青霉索治疗上呼吸道感染125例临床分析[J].中医药学报,1993,3,12-13.
[70]毛梅仙.莪术油注射液治疗小儿病毒性肠炎[J].Herald of Medicine,2002,21,298-291.
[71]夏治群,董启.莪术油治疗小儿病毒性肠炎疗效观察[J].中医药信息,1999,5,37-39.
[72]王培养.莪术油注射液治疗小儿手足口病疗效观察[J].浙江中西医结合杂志,2003,13,437-439.
[73]诸锦春.莪术油治疗小儿呼吸道感染的疗效观察[J].儿科药学杂志,2003,9,52-54.
[74]程国平,刘明海.莪术油治疗流行性腮腺炎的临床对照实验[J].药物流行病学杂志,1999,8,203-204.
[75]吴建敏.莪术油葡萄糖注射液治疗急性病毒性脑炎疗效观察[J].海峡药学,2003,15,49-50.
[76]魏玉平,骆志成.莪术挥发油体外抗念珠菌活性的研究[J].中国麻风皮肤病杂志,2005,21, 524-526.
[77]毛春芹,谢辉等.术炮制品的抗血小板聚集及抗凝血作用[J].中药材,2000,23,212-213.
[78]唐泽耀,宗成国.林原莪术醇的活血化瘀活性实验研究[J].中药药理与临床,2003,19,15-15.
[79]陆群,谢梅林,等.榄香烯乳抑制大鼠血小板聚集的机理研究[J].苏州医学院学报,1996,16,844-846.
[80]魏兰福,邹百仓,等.莪术对大鼠胃动力影响的实验研究[J].湖南中医杂志,2003,19,58-59.
[81]魏兰福,邹百仓,等.莪术对实验大鼠胃动力的影响[J].上海中医药杂志,2003,37,46-48.
[82]魏兰福,邹百仓,等.莪术对实验性功能性消化不良大鼠胃排空的影响[J].南京医科大学学报(自然科学皈),2003,23,350-352.
[83]饶伟文.癌胚共性与抗生育中草药的抗肿瘤作用[J].中草药,1997,28,178-180.
[84]李希新,张恒齐.论妊娠禁忌药在妊娠期的应用[J].山东中医杂志,1999,18,368-70.
[85]李莲姬,韩春姬.莪术对老年小鼠学习记忆与脂质过氧化作用的影响[J].中药材,1998,21,522-523.
[86]黄可新,潘建春.温莪术丙酮部分抗动物惊厥作用的研究[J].中国药理学会通讯,2000,17,56-56.
[87]宋智琦,韩世新.莪术油霜剂外用治疗银屑病的药效学及作用机制研究[J].中国皮肤性病学杂志,2001,15,301-303.
[88]韩铭钧,等.油性中药抗癌剂OCC肝动脉栓塞治疗肝癌84例3年随访报告[J].临床放射学杂志,1998,17,112-114.
[89]谭立欣,等.抗癌新药榄香烯乳治疗晚期患者肿瘤的临床评价[J].中国中药信息杂志,1997,4,11-12.
[90]汪伟民,等.中药莪术油对小鼠Lewis肺癌抑制作用的实验研究[J].中国中医药科技,2003,10,353-354.
[91]糜福顺,等.莪术油对肺腺癌(LA-795)的放射增敏作用[J].中华放射医学与防护杂志,1992,6,405-407.
[92]王新生,王成芬,王利燕.莪术油葡萄糖注射液治疗病毒性肺炎的治疗观察[K].中医药研究,2000,16,16-19.
[93]张穗,黄又新,高素军.莪术油注射液治疗小儿急性甲型病毒性肝炎39例[J].中西医结合肝病杂志,1994,4,36-39.
[94]杨卫民,雷林东,张辉,等.莪术油滴眼液治疗单疱疹性角膜炎的临床观察[J].眼科研究, 2000,18,192.
[95]庞国明,等.常用药物新用途临床大全[M].北京.中国医药出版社,1993,635.
[96]U.S.Dispensatory[M].24ED,1947:1652.
[97]任王华.莪术油胶丸治疗消化性溃疡的临床观察[J].实用中西医结合杂志。1990,3,164-165.
[98]宋智琦,林煦然.外用莪术油霜剂治疗银屑病[J].华皮肤科杂志,1998,31,124-127.
[99]戴兴冬,王德玲,常宝月.莪术油治疗过敏性紫癜72例[J].吉林中医药,1998,18,37-39.
[1]Syu W J,Shen C C.Don M J.et.al.Cytotoxicity of Curcuminoids and Some Novel Compounds from Curcuma zedoaria[J].J.Nat.Prod.1998,61,1531-1534.
[2]Wang Q,Mu Q,Shibano M.et.al.Eremophilane Sesquiterpenes from Ligularia macrophylla[J].J.Nat.Prod.2007,70,1259-1262.
[3]Wu B.He S,Wu X D,et.al.New tyrosinase inhibitory sesquiterpenes from Chloranthus henryi[J].Chem.Biodivers.2008,5,1298-1303.
[4]Yang S P,Zhang C R,Chen H D,et.al.Sesquiterpenoids from Chloranthus spicatus(Thunb.)Makino[J].Chinese J.Chem.2007,25,1892-1895.
[5]Zdero C,Bohlmann F,Haegi L,et.al.Eudesmanolides and other constituents from Cratystylis conocephala[J].Phytochemistry 1988,27,865-868.
[6]Boriky D,Berrada M,Talbi M,et.al.Eudesmanolides from Artemisia herba-alba[J].Phytochemistry 1996,43,309-311
[7]Takano I,Yasuda I,Takeya K,et.al.Guaiane sesquiterpene lactones from Curcuma aeruginosa[J].Phytochemistry 1995,40,1197-1200.
[8]Kuroyanagi M,Ueno A,Ujiie K,et.al.Structures of sesquiterpenes from Curcuma aromatica Salisb[J].Chem.Pharm.Bull.1987,35,53-59.
[9]Masuda T,Jitoe A,Nakatani N.Structure of aerugidiol,a new bridge-head oxygenated guaiane sesquiterpene[J].Chem.Lett.1991,9,1625-1628.
[10]Snatzke G.Circular dichroism.Ⅷ.Modification of the octant rule for α,β-unsaturated ketones;theory[J].Tetrahedron 1965,21,413-419.
[11]Snatzke G,Circular dichroism.X.Modification of the octant rule for α,β-unsaturated ketones;cisoid enones,dienones,and aryl ketones[J].Tetrahedron 1965,21,421-438.
[12]Snatzke G,Circular dichroism.Ⅸ.Modification of the octant rule for α,β-unsaturated ketones;transoid enones[J].Tetrahedron 1965,21,438-448.
[13]Zhu H J,Ren J,Pittman C U,Jr.Matrix Model to Predict Specific Optical Rotations of Acyclic Chiral Molecules[J].Tetrahedron 2007,63,2292-2314.
[14]Zhu H J,Modern Organic Stereochemistry[M],Science Press,Beijing,2009,Chapter 1,p.16-38.
[15]Kristina J S.Karsten S,Jasmin J,et.al.Sipandinolide:a butenolide including a novel type of carbon skeleton from Siparuna andina[J].Planta Med.2000,66,384-385.
[16]Giang P M,Son P T.Matsunami K.et.al.New sesquiterpenoids from Curcuma aff.aeruginosa Roxb[J].Heterocycle 2007.74,977-981.
[17]Watson W H,Kashyap R P.Conformations of germacra-l(10).4-dien-6,12-olides and-8.12-olides.A comparison of x-ray diffraction,NMR.and molecular mechanics derived conformations[J].J.Org.Chem.1986.51,2521-2524.
[18]Kotsos M P,Aligiannis N,Myrianthopoulos V,et.al.Sesquiterpene Lactones from Staehelina fruticosa[J].J.Nat.Prod.2008.71.847-851.
[19]Riingeler P.Brecht V,Tamayo-Castillo G,et.al.Germacranolides from Mikania guaco[J].Phytochemistry 2001.56,475-489.
[20]Tashkhodzhaev B,Sham'yanov I D,Izbosarov M B.et.al.Crystal and molecular structure of 13-diethanolamino-deacetyllaurenobiolide.Macrocycle conformation in linear germacrolides[J].Chem.Nat.Compd.2004.40.552-556.
[21]Lange G L,Lee M.Carbon-13 NMR determination of the configuration of methyl-substituted double bonds in medium-and large-ring terpenoids[J].Magn.Reson.Chem.1986.24.656-658.
[22]Chen Z L,Cao W Y,Zhou G X.A sesquiterpene lactam from Artractylodes macrocephala[S].Phytochemistry 1997.45.765-767.
[23]Kuroyanagi M,Ueno A.Koyama K.et.al.Structures of sesquiterpenes of Curcuma aromatica Salisb[J].Ⅱ.Studies on minor sesquiterpenes.Chem.Pharm.Bull.1990,38,55-8.
[24]Ohshiro M,Kuroyanagi M,et.al.Structures of sesquiterpenes from Curcuma longa[J].Phytochemistry 1990.29,2201-2205.
[25]Kasahara K,Nomura S.Subeki,et.al.Anti-babesial compounds from Curcuma zedoaria[J].Planta Med.2005.71,482-484.
[26]Matsuda H,Morikawa T,Toguchida I,et.al.Medicinal foodstuffs.XXVIII.Inhibitors of nitric oxide production and new sesquiterpenes,zedoarofuran,4-epicurcumenol,neocurcumenol,gajutsulactones A and B.and zedoarolides A and B,from Zedoariae Rhizoma[J].Chem.Pharm.Bull.2001,49,1558-1566.
[27]Shiobara Y,Iwata T,Kodama M,et.al.Biomimetic transformation of dehydrocurdione into curcumenol and isocurcumenol and their stereochemistries[J].Tetrahedron Lett.1985.26,913-916.
[28]Hiroshi H,Kangi M.et.al.Srtucture of curcumol[J].Chem.Pharm.Bull.1966,14:1241-1249.
[29]Yoshikawa M,Yamaguchi S,Matsuda H,et.al.Crude drugs from aquatic plants.Ⅳ.on the constituents of alismatis rhizome.(2).Stereostructures of bioactive sesquiterpenes alismol,alismoxide,orientalols A,B,and C,from Chinese alismatic rhizome[J].Chem.Pharm.Bull.1994,42,1813-1816.
[30]Oshima Y,Iwakawa T,Hikino H.Alismol and alismoxide,sesquiterpenoids of alzsma rhizomes[J].Phytochemistry,1983,22,183-185.
[31]Seiichi I,Gao J E et.al.Stereostructure of curdione[J].Chem.Pharm.Bull.1985,33:1323-1326
[32]Yoshihara M,Shibuya H,et.al.The absolute sterostructure of(4S,5S)-(+)- germacrone 4,5-epoxide from Zedoariae rhizome cultivated in Yakushima island[J].Chem.Pharm.Bull.1984,32,2059-2062.
[33]Harimaya K,Gao J F,Ohkura T.et.al.A series of sesquiterpenes with a 7-isopropyl side chain and related compounds isolated from Curcuma wenyujin[J].Chem.Pharm.Bull.1991,39.843-853.
[34]Matsuda H,Morikawa T,Ninomiya K,et.al.Absolute stereostructure of carabrane-type sesquiterpene and vasorelaxant-active sesquiterpenes from Zedoariae Rhizoma[J].Tetrahedron 2001,57,8443-8453.
[35]Friedrich D,Bohlmann F.Total synthesis of various elemanolides[J].Tetrahedron 1988,44,1369-1392.
[36]Kikuzaki H,Nakatani N.Cyclic diarylheptanoids from rhizomes of zingiber officinale[J].Phytochemistry 1996,43,273-277.
[37]Yi J H,Chen Y,et.al.Studies on chemical constituents of the tubers of curcuma longa[J].Natural Product Research and Development 2003,15,98-100.
[38]Chiang Y M,Liu H K.Cytotoxic constituents of the leaves of Calocedrus fomosana[J].Journal of the Chinese Chemical Society.2003,50(1):161-166.
[39]于德全,杨峻山,等.分析化学手册第二版第七分册[M],核磁共振波谱分析,化学工业出版社,822
[1]Kageura T,Matsuda H,Morikawa T,et al.Inhibitors from Rhubarb on Lipopolysaccharide-Induced Nitric Oxide Production in Macrophages:Structural Requirements of Stilbenes for the Activity.Bioorg.Med.Chem.2001,9,1887-1893.
[2]归莉琼,魏东芝.NO:一种重要的生物信使分子.生命科学 1998,10,188-190.
[3]郑永晨,杨贵贞.一氧化氮与巨噬细胞的免疫调节.国外医学免疫学分册1995,4,204-206.
[4]胡章颜.一氧化氮与细胞凋亡的研究进展.江西医学院学报2005,45,176-178.
[5]王媛,柏树令.一氧化氮合酶与主动脉瘤.解剖科学进展2005,11,268-272.
[6]Hidashi M,Toshio M,et.al.Medicinal foodstuffs ⅩⅩⅧ:Inhibitors of nitric oxide production and new sesquiterpenes,zedoarofuran,4-epicurcumenol,neocurcumenol,gajutsulactones A and B,and zediarolides A and B,from zedoariae rhizoma[J].Chem.Pharm.Bull.2001,49,1558-1566.
[7]Hidashi M,Toshio M,et.al.Absolute stereostructure of carabrane-type sesquetepene and vasorelaxant-active sespuiterpenes from zedoariae rhizoma[J].Tetrahedron 2001,57,8443-8453.
[8]Dirsch V M,Stuppner H,Vollmar A M.The Griess assay:suitable for a bioguided fractionation of anti-inflammatory plant extracts.Planta Med 1998,64,423-426
[1]Guerra M C,Speronil Comparison between Chinese medical herb Pueraria lobata crude extract and its main isoflavone puerarin Antioxidant properties and effects on rat liver CYP-catalysed drug metabolism[J],Pharmacology letters 2000,67,2997-3001.
[2]左风,严梅桢,周钟鸣.肠道菌群对中药有效成分代谢作用的研究[J].中国中药杂志2002,27,568-571.
[3]孙艳,李雪驼,殷素兰.肠道内微生态环境对中草药体内代谢的影响[J].中草药2001,32,375-378.
[4]刘明杰,林琳,王钊.肠道菌群对天然药物代谢的研究进展Ⅰ[J].中国现代应用药学2001,18,90-93.
[5]刘明杰,林琳,王钊.肠道菌群对天然药物代谢的研究进展Ⅱ[J].中国现代应用药学2001,18,257-259.
[6]严梅桢.人肠道菌对柴胡皂甙的代谢[J].国外医学中医中药分册2001,3,156-159.
[7]钟大放.液相色谱-质谱联用法在药物研究中的应用[J].世界科学技术-中药现代化2003,5,44-47.
[8]李慧义,罗淑荣.液相色谱-质谱联用及其在药物代谢研究中的应用[J].国外医学--药学分册1997,24,257-263.
[9]杨春,司伊康.药物代谢研究中的核磁共振技术[J].药物分析杂志1999,19,422-26.
[10]丁黎,张正行,安登魁.药物代谢物结构研究中的色谱-光谱联用技术[J].药学进展2000,24,200-204.
[11]梁剑平,卫增泉,张力.稳定同位素在药物动力学研究中的新进展[J].原子核物理评论1998,15,110-114.
[12]孙晖,吴泽明.中药及其复方的体内代谢研究现状与未来发展[J].世界科学技术-中药现代化2006,8,1-6
[13]朱大元,黄宝山,陈仲良,等,人体代谢青蒿素转化物的分离和鉴定[J].中国药理学报1983,4,194-197.
[14]李志,王堃,陈玉仁,吴秀英,苏成业.大鼠胆汁中β-榄香烯代谢产物的研究[J].药学学报2000,35,829-831.
[15]陈昕,周秋丽,王本祥.人参皂苷Rb1在大鼠肠内菌代谢物吸收入血成分的研究[J].药学 学报1999,34,410-412.
[16]陈昕,周秋丽,王本祥.人参皂苷Rb1在大鼠肠内菌代谢物吸收入血成分的研究[J].药学学报1999,34,481-483.
[17]Cui L,Qiu F,Yao XS.Isolation and identification of seven glucuronide conjugates of andrographolide in human urine.[J].Drug Metab.Dispos.2005,33,555-562.
[18]He XJ,Qiu F,Yao XS.identification of a rare sulfonic acid metabolite of andrographolide in rats [J].Drug Metab.Dispos.2003,31,983-985.
[19]彭仕华,崔燕岩,周同惠.氯代正丁苯酞在大鼠肝微粒体中的代谢研究[J].药学学报1996,31,780-784.
[20]Qiu F,Zhu ZY,Kang N,et al.Isolation and identification of urinary metabolites of berberine in rats and humans.[J].Drug Metab.Dispos.2008,36,2159-2165.
[21]Cheng WM,Qiu F,Yao XS.Three major urinary metabolites of sinomenine in rats[J].J Asian Nat.Prod.Res.2007,9,山版 13-18.
[22]江骥,姜国辉,叶云鹏,等.川芎嗪的体内代谢[J].中国医学科学院学报,1993,15,79.
[23]张文江,周同惠.海南粗榧新碱衍生物HH07A在大鼠体内的代谢转化研究[J].药学学报,1998,33,212-216.
[24]林沐彬,张伟,赵学文,等.粉防己碱在体内的代谢转化[J].药学学报1982,7,728-730.
[25]邱峰,陈英杰,鹿野美弘,等.淫羊藿苷在大鼠体内的代谢[J].药学学报1999,34,222-226.
[26]Qiu F,Xia HJ,Zhang TY,Di X,et al.Two Major Urinary Metabolites of Scutellarin in Rats[J].Planta Med.2007,73,363-365.
[27]张军,杨克文.葛根素在大鼠尿和胆汁中的代谢物[J].国外医学-中医中药分册1996,18,46.
[28]薛明,崔颖,汪汉卿,罗永江,张彬,周宗田。隐丹参酮及其代谢物在猪体内的药代动力学研究[J].药学学报1999,34,81-84.
[29]薛廷民,番泻苷C在小鼠体内的代谢活化-与蒽酮的协同作用[J].国外医药-植物药分册1993,8,84-85.
[30]游金辉,谭天秩,匡安仁,等.~3H-天麻苷元和~3H-天麻素在小鼠体内的分布和代谢[J].华西医科大学学报1994,25,325-328.
[31]Zeng YC,Qiu F,Liu Y,Qu GX,Yao XS.Isolation and Identification of Phase 1 Metabolites of Demethoxycurcumin in Rats[J].Drug Metab.Dispos.2007,35,1564-1573.
[32]薛社菁,等,医学研究通报,1988,7,26-29.
[33]Feng Qiu,Kenichi Komatsu.et al.Pharmacokinetical Study of Mulberroside A and Its Metabolites in Rat[J].Biol.Pharm.Bull.1996,19,1463-1467.
[34]XIA HJ,Qiu E Zhu S,et al.Isolation and Identification of Ten Metabolites of Breviscapine in Rat Urine[J].Biol.Pharm.Bull.2007,30,1308-1316.
[35]杨异卉,朱志勇,陈丽霞,邱峰.人口服黄连水煎液尿中化学成分的分离鉴定[A].2008年中国药学会学术年会暨第八界全国中药和天然药物学术研讨会.
[36]雷厉,宋志宏,李寅增,等.管花肉从蓉苯乙醇总苷在狗胃肠道内的生物转化[J].药学学报2001,36,432-435.
[37]师少军,陈汇,曾繁典.中药复方药物代谢动力学研究方法及展望[J].中国临床药理学杂志2001,17,235-238.
[38]吴立军,王本祥.参附汤体内代谢化学成分的初步研究[J].沈阳药科大学学报 2001,18,23-26.
[39]苏成业,刘金友,许洪霞.~3H-莪术醇在正常大鼠及肿瘤小鼠体内的代谢研究[J].药学学报,1980,15,257-262.
[1]Zhang H,Qiu F,Yao XS,QU GX.Microbial transformation of curcumol by Cunninghamella blakesleana[J].J Asian Nat Prod Res.2007,9,311-9.
[2]张卉,莪术醇的微生物转化及大鼠体内代谢产物研究,沈阳药科大学博士论文,2005,pp 64-73.
[1]费健康,孔宪章.莪术醇注射液处方的改进[J].药学通报.1980,15,491-92.
[2]游金辉,谭天秩,匡安仁,等.~3H-天麻苷元和~3H-天麻素在小鼠体内的分布和代谢[J].华西医科大学学报.1994,25,325-328.
[1]张卉,莪术醇的微生物转化及大鼠体内代谢产物研究,沈阳药科大学博士论文,2005,pp24-30.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |